RESUMO
PURPOSE: To report the safety and effectiveness of fibrin sheath stripping of pediatric chest ports. MATERIALS AND METHODS: Fibrin sheath stripping procedures for pediatric chest ports between 2018 and 2023 were retrospectively reviewed. The treatment indication was the inability to aspirate blood from the port. The technical success, adverse events, days of primary and secondary service intervals, fluoroscopy time, and fluoroscopy dose were recorded. RESULTS: Fibrin sheath stripping procedures were performed in 15 patients for a total of 18 procedures. All patients treated with fibrin sheath stripping had failed fibrinolytic treatment and a preprocedural fluoroscopy examination suggestive of fibrin sheath before attempting stripping. All fibrin sheath stripping procedures were technically successful. The median and mean total days of primary service interval from the date of port placement to the date of suspected fibrin sheath were 666 and 617 days, respectively. The median and mean total number of days of secondary service interval were 385 and 561 days, respectively. The mean fluoroscopy time was 16.9 minutes. The mean fluoroscopy air kerma was 29.8 mGy. No adverse events were observed. CONCLUSIONS: Fibrin sheath stripping is a safe and effective minimally invasive option to maintain the function of pediatric chest ports.
Assuntos
Fibrina , Humanos , Estudos Retrospectivos , Feminino , Masculino , Pré-Escolar , Resultado do Tratamento , Criança , Fatores de Tempo , Lactente , Radiografia Intervencionista , Adolescente , Cateterismo Venoso Central/instrumentação , Cateterismo Venoso Central/efeitos adversos , Fluoroscopia , Cateteres de Demora , Fatores de Risco , Doses de Radiação , PunçõesAssuntos
Malformações Arteriovenosas , Embolização Terapêutica , Artéria Pulmonar , Veias Pulmonares , Recidiva , Feminino , Humanos , Malformações Arteriovenosas/diagnóstico por imagem , Malformações Arteriovenosas/terapia , Malformações Arteriovenosas/cirurgia , Embolização Terapêutica/instrumentação , Artéria Pulmonar/diagnóstico por imagem , Artéria Pulmonar/anormalidades , Artéria Pulmonar/cirurgia , Veias Pulmonares/anormalidades , Veias Pulmonares/diagnóstico por imagem , Veias Pulmonares/cirurgia , Resultado do Tratamento , Pessoa de Meia-IdadeRESUMO
While a plethora of articles discuss management of deep venous thromboses in extremities, there is a relative scarcity of literature comprehensively describing intra-abdominal venous thromboses, and their management. Intra-abdominal venous thromboses include iliocaval venous obstruction (ICVO), hepatic venous thrombosis (HVT), portal venous thrombosis (PVT), renal vein thrombosis (RVT), splenic vein thrombosis (SVT), and gonadal vein thrombosis (GVT); each of which provides unique microenvironmental challenges to management. Doppler ultrasound is the first line imaging modality for diagnosis, and computed tomography and magnetic resonance imaging can help define the extent of thrombus burden and aid with interventional planning. Systemic anticoagulation remains the common medical treatment for intra-abdominal venous thrombosis, however, catheter directed thrombolysis and thrombectomy show positive outcomes in ICVO, HVT, PVT, and RVT, with transjugular intrahepatic portosystemic shunt (TIPS) creation especially beneficial in HVT and PVT. In this review article, we describe pathophysiology, clinical features, imaging findings, and current management options for intra-abdominal venous thromboses.